HK1097474A1 - Carbostyril derivatives for accelerating salivation - Google Patents

Carbostyril derivatives for accelerating salivation

Info

Publication number
HK1097474A1
HK1097474A1 HK07102814.3A HK07102814A HK1097474A1 HK 1097474 A1 HK1097474 A1 HK 1097474A1 HK 07102814 A HK07102814 A HK 07102814A HK 1097474 A1 HK1097474 A1 HK 1097474A1
Authority
HK
Hong Kong
Prior art keywords
salivation
accelerating
carbostyril
xerostomia
prophylaxis
Prior art date
Application number
HK07102814.3A
Other languages
English (en)
Inventor
Hisashi Nagamoto
Masayuki Kohashi
Hiroshi Oka
Original Assignee
Otsuka Pharma Co Ltd
Univ School St Marianna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Univ School St Marianna filed Critical Otsuka Pharma Co Ltd
Publication of HK1097474A1 publication Critical patent/HK1097474A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
HK07102814.3A 2003-07-30 2007-03-15 Carbostyril derivatives for accelerating salivation HK1097474A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003282691 2003-07-30
JP2004021808 2004-01-29
PCT/JP2004/009992 WO2005011811A1 (en) 2003-07-30 2004-07-07 Carbostyril derivatives for accelerating salivation

Publications (1)

Publication Number Publication Date
HK1097474A1 true HK1097474A1 (en) 2007-06-29

Family

ID=34117911

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07102814.3A HK1097474A1 (en) 2003-07-30 2007-03-15 Carbostyril derivatives for accelerating salivation

Country Status (10)

Country Link
US (1) US7879877B2 (xx)
EP (1) EP1648563B1 (xx)
JP (1) JP4394686B2 (xx)
KR (1) KR100681360B1 (xx)
CN (1) CN1859948B (xx)
AT (1) ATE373502T1 (xx)
DE (1) DE602004009079T2 (xx)
HK (1) HK1097474A1 (xx)
MY (1) MY142739A (xx)
WO (1) WO2005011811A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1863466B1 (en) 2005-03-03 2017-08-09 Takasago International Corporation (USA) Synergistic salivation components
CN101910116B (zh) 2008-01-18 2013-06-19 高砂香料工业株式会社 (2e，6z，8e)-n-异丁基-2，6，8-癸三烯酰胺(千日菊酰胺)的制备方法，以及包含该化合物的食品或饮料、香料或化妆品、或药物
US8741930B2 (en) * 2008-10-24 2014-06-03 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
CN103476753B (zh) 2011-02-25 2015-12-09 诺弗米克斯有限公司 新的瑞巴派特复合物和共晶体
US20140010882A1 (en) 2011-03-24 2014-01-09 Takakuni Matsuda Pharmaceutical composition for treating a disease in the oral cavity comprising rebamipide
JP6710040B2 (ja) * 2015-11-06 2020-06-17 江崎グリコ株式会社 唾液分泌促進剤及び口腔用組成物
KR102190019B1 (ko) * 2018-10-23 2020-12-15 삼진제약주식회사 쇼그렌 증후군 예방 또는 치료용 조성물
EP4001434A3 (en) * 2020-11-18 2022-08-10 Korea Institute of Science and Technology Salivary biomarker for diagnosing xerostomia and use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322425A (en) * 1980-03-14 1982-03-30 Otsuka Pharmaceutical Co., Ltd. Compositions for treating glaucoma
US4578381A (en) 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP2812998B2 (ja) 1989-08-14 1998-10-22 大塚製薬 株式会社 胃炎治療剤
DK0543018T3 (da) * 1991-06-07 1996-02-05 Otsuka Pharma Co Ltd Antidiabetikum
TW227558B (xx) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤
CA2136108A1 (en) 1993-03-18 1994-09-29 Makoto Sakamoto Carbostyril derivatives as matrix metalloproteinases inhibitors
JP2839827B2 (ja) 1993-10-05 1998-12-16 大塚製薬株式会社 ウレアーゼ阻害剤
WO1995011026A1 (en) * 1993-10-21 1995-04-27 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative for inhibiting production of interleukin-8
EP0774968A1 (en) 1994-08-10 1997-05-28 Otsuka Pharmaceutical Co., Ltd. Method of preventing and treating ophthalmic inflammation and/or wound
JPH0971532A (ja) 1995-09-06 1997-03-18 Otsuka Pharmaceut Co Ltd 発癌抑制剤
AR004214A1 (es) * 1995-10-12 1998-11-04 Otsuka Pharma Co Ltd Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
AU5410998A (en) 1996-12-16 1998-07-15 Otsuka Pharmaceutical Co., Ltd. Adp-ribosyltransferase inhibitor
JPH11228413A (ja) 1998-02-20 1999-08-24 Otsuka Pharmaceut Co Ltd Ｎａｄアーゼ阻害剤

Also Published As

Publication number Publication date
EP1648563A1 (en) 2006-04-26
EP1648563B1 (en) 2007-09-19
DE602004009079D1 (de) 2007-10-31
KR20060037408A (ko) 2006-05-03
CN1859948A (zh) 2006-11-08
JP4394686B2 (ja) 2010-01-06
US20070112026A1 (en) 2007-05-17
JP2006528662A (ja) 2006-12-21
DE602004009079T2 (de) 2008-06-19
MY142739A (en) 2010-12-31
KR100681360B1 (ko) 2007-02-12
WO2005011811A1 (en) 2005-02-10
CN1859948B (zh) 2010-05-26
ATE373502T1 (de) 2007-10-15
US7879877B2 (en) 2011-02-01

Similar Documents

Publication Publication Date Title
HK1097474A1 (en) Carbostyril derivatives for accelerating salivation
BR0317572A (pt) Benzoxazinas e seus derivados como inibidores de pi3ks
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
WO2005046589A3 (en) Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
UA94901C2 (ru) Антибактериальные производные пиперидина
WO2006005609A3 (de) Substituierte oxindol-derivate und diese enthaltende arzneimittel
NO20052182L (no) Nye forbindelser
AU2003228674A1 (en) Muscarinic antagonists
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
TW200730176A (en) Formulations of quinolinones
NO20040881L (no) Orale antidiabetes midler.
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
CA2469592A1 (en) Hiv integrase inhibitors
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
WO2002060423A3 (en) Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
MXPA04006041A (es) Antivirales de piridoquinoxalina.
CA2437785A1 (en) Hiv inhibiting pyrazinone derivatives
AU2003223340A1 (en) Certain pharmaceutically useful substituted aminoalkyl heterocycles
WO2001081316A3 (en) Substituted phenyl farnesyltransferase inhibitors
WO2006103544A8 (en) 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
SG166799A1 (en) Quinoline derivatives as antibacterial agents
AU2002248531A1 (en) Pyrazolopyriadine derivatives
WO2004089943A8 (en) Antimicrobial [3.1.0] bicyclohexylphenyl-oxazolidinone derivatives and analogues
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180707